Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?

Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors

(2012) R. Sanchon et al.   HUMAN REPRODUCTION

Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study

(2011) TB Eilertsen et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Antimüllerian hormone and polycystic ovary syndrome

(2011) Yi-Hui Lin et al.   FERTILITY AND STERILITY

Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

(2011) Bart C.J.M. Fauser et al.   FERTILITY AND STERILITY

Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries

(2011) D. Dewailly et al.   HUMAN REPRODUCTION

The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study

(2011) Fahimeh Tehrani et al.   Reproductive Biology and Endocrinology

The journey from the old to the new AMH assay: how to avoid getting lost in the values

(2011) S.M. Nelson et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women

(2010) Ingrid J. M. Duijkers et al.   GYNECOLOGICAL ENDOCRINOLOGY

A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?

(2010) S. L. Kristensen et al.   HUMAN REPRODUCTION

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

(2010) Lisa J. Moran et al.   HUMAN REPRODUCTION UPDATE

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Müllerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism

(2010) Didier Dewailly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Levels of Anti-Müllerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome Patients

(2010) Casper P. Hagen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

(2010) Laura Pellatt et al.   REPRODUCTION

Sex ratio and pregnancy complications according to mode of conception in women with polycystic ovary syndrome

(2009) Eszter Vanky et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

The antral follicle count: practical recommendations for better standardization

(2009) Frank J.M. Broekmans et al.   FERTILITY AND STERILITY

The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome

(2009) L. G. Nardo et al.   HUMAN REPRODUCTION

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

(2009) W. A. March et al.   HUMAN REPRODUCTION

Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome

(2009) S.M. Carlsen et al.   HUMAN REPRODUCTION

Anti-Müllerian hormone and ovarian dysfunction

(2008) Frank J. Broekmans et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM